Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission. Issue 1 (6th November 2019)

• Record Type: Journal Article
• Authors: Shankar, Uday; Vijayasekar, Kavitha; Bansal, Raghav; Walfish, Aaron
• Is Part Of: Inflammatory bowel diseases. Volume 26:Issue 1(2020)
• Page Start: e3
• Page End: e3
• Publication Date: 2019-11-06
• Subjects: rituximab -- Crohn's disease -- ustekinumab; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izz270
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract : Rituximab-induced Crohn's disease is a rare entity with very little literature on its management. We report the first case of this condition treated successfully with ustekinumab induction and long-term maintenance of remission.